Showing results (651-660 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|March 10, 2018
Biological imaging for individualized therapy in radiation oncology: part I physical and technical aspectsMark Gainey, Montserrat Carles, Michael Mix, et al.
Future Oncology (London, England)|August 17, 2017
Bevacizumab in advanced lung cancer: state of the artSandra Assoun, Solenn Brosseau, Christelle Steinmetz, et al.
Future Oncology (London, England)|March 27, 2018
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenibMaria Grazia Lucà, Roberto Nani, Melanie Schranz, et al.
Future Oncology (London, England)|January 30, 2019
Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profilingJohn T Vetto, Eddy C Hsueh, Brian R Gastman, et al.
Future Oncology (London, England)|January 19, 2019
Comparison of different prognostic models for predicting cancer-specific survival in bladder transitional cell carcinomaChuiGuo Huang, WeiWen Zhou, Pan Song, et al.
Future Oncology (London, England)|November 1, 2019
Bifidobacterium spp: the promising Trojan Horse in the era of precision oncologyNealie Ngo, Khalil Choucair, Justin F Creeden, et al.
Future Oncology (London, England)|October 27, 2017
The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumorsAmit Tirosh, Electron Kebebew
Future Oncology (London, England)|February 6, 2018
Single-institution experience of intensity-modulated radiotherapy for malignant pleural mesothelioma at University of CataniaCorrado Spatola, Carmelo Militello, Alessandra Tocco, et al.
Future Oncology (London, England)|February 6, 2018
Is it appropriate to perform video-assisted thoracoscopic surgery for advanced lung cancer?David Sanchez-Lorente, Rudith Guzman, Marc Boada, et al.
Future Oncology (London, England)|January 30, 2018
Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapiesFederico Cappuzzo, Ross Soo, Maximilian Hochmair, et al.
Pageof 452